Promoting technology transfer
The Research Applications and Industrial Relations Department (DARRI) turns Institut Pasteur technologies and innovations into progress in diagnosis, vaccines, therapy and technology for the benefit of patients:
- by developing industrial partnerships and with investment funds,
- by promoting Institut Pasteur discoveries,
- by protecting these innovations (invention disclosures, patent applications, etc.),
- by transferring these inventions to industrial partners in France and abroad (licensing agreements on filed patents, research partnerships, creation of start-up businesses, etc.).
Technology transfer and the development of industrial partnerships are among the Institut Pasteur’s historical callings. They generate essential resources for the Institut Pasteur, boost funding for new projects, and benefit public health.
To successfully fulfill its role, the DARRI has many strengths, including:
- the Institut Pasteur is home to the "Pasteur Microbes and Health" Carnot Institute. Carnot Institutes are organizations that are efficient in forging links with industrial stakeholders in their areas of expertise. This is the case of the Institut Pasteur, which is renowned for its ability to foster innovation and research partnerships in microbiology and human health.
- Bioaster, the Technology Research Institute funded under the French 'Grand Loan' plan and specialized in technological innovation in microbiology, which is supported by top level academic and industrial partners — CEA, CNRS, Inserm, Danone Nutricia Research, Institut Mérieux and Sanofi Pasteur.
- a global technology transfer team within the Institut Pasteur International Network.
The Institut Pasteur is in the top 10* best institutions worldwide in terms of patent registration.
*Research Biotech Patenting 2014, Brady Huggett & Kathryn Paisner Nature Biotechnology, July 2015.
Director of the Research Applications and Industrial Relations Department (DARRI)
Innovation protection promotes the Institut Pasteur’s vast scientific expertise. Industrial partnerships [licenses] enable patients to benefit from these discoveries through the development of diagnostic tools or new treatments. Industrial partnerships [collaboration agreements] also enable us to directly fund effective research that meets both global public health challenges and the need for knowledge of fundamental processes.